BACK TO GROWTH, BACK TO BUSINESS
ASBIS DELIVERS ITS MOST PROFITABLE EVER QUARTER 1
Q1 2023 RESULTS
TABLE OF CONTENT
ASBIS - Q1 2023 OVERVIEW FINANCIAL RESULTS IN Q1 2023 FINANCIAL FORECAST FOR 2023 DIVIDEND FOR 2022 SUMMARY
APPENDIX
2
Q1 2023 KEY BUSINESS EVENTS
STRONG MONTHLY
REVENUES
BUSINESS GROWTH
FINAL DIVIDEND
AMBITIOUS FORECAST
Very strong Q1 of 2023 for ASBIS. The Company has beaten its March record-breaking revenues reaching an immense 30% growth rate.
- ASBIS has established a subsidiary in Greece, ASBIS Hellas S.A.
- ASBIS has invested in Theramir LTD - biotech company which develops stem cell and RNA based technologies for the diagnosis and treatment of cancer disease
- Breezy, a subsidiary of ASBIS, due to the dynamic development, started operating on two more markets: Poland and Moldova
- ASBIS doubled its robotic commercial division - ASBIS Robotic Solutions (AROS) and started operations of this division in new countries such as Hungary and Bulgaria as well as in the Middle East and North Africa (MENA Region).
Annual General Meeting of Shareholders decided to pay out a final dividend from the Company's 2022 profits for the amount of USD 0.25 per share.
The Company announced its financial forecast for 2023: | : |
- revenues between US$ 3.0 and US$ 3.2 billion
- net profit after tax between US$ 78.0 and US$ 82.0 million.
3
ASBIS IN Q1 2023
Subsidiaries in 28 countries
Revenue $ 722 m
20 B2B e-shops
- B2C e-commerce
20 000
active customers in 60 countries
4 Distribution centers
Over
240
vendors
- 485 employees
110 000 products in portfolio
60%
Online transactions
4
TABLE OF CONTENT
ASBIS - Q1 2023 OVERVIEW FINANCIAL RESULTS IN Q1 2023 FINANCIAL FORECAST FOR 2023 DIVIDEND FOR 2022 SUMMARY
APPENDIX
5
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
ASBISc Enterprises plc published this content on 12 May 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 12 May 2023 08:42:11 UTC.